ViaCyte Selected as a Finalist for CONNECT's 30th Annual Most Innovative New Product Awards

Thursday, September 21, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Developing PEC-Direct to address urgent medical need in patients with high-risk type 1 diabetes

ViaCyte logo


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook